tiprankstipranks
Legend Biotech Corporation (LEGN)
NASDAQ:LEGN
US Market
LEGN
Legend Biotech
RESEARCH TOOLSreports
Want to see LEGN full AI Analyst Report?

Legend Biotech (LEGN) Income Statement

689 Followers

Legend Biotech Income Statement

Last quarter (Q1 2026), Legend Biotech's total revenue was $306.01M, an increase of 56.89% from the same quarter last year. In Q1, Legend Biotech's net income was $-54.46M. See Legend Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.03B$ 627.24M$ 285.14M$ 117.00M$ 68.83M
Gross Profit
$ 620.80M$ 392.66M$ 140.93M$ 51.64M$ 68.83M
Operating Expenses
$ 757.30M$ 695.90M$ 580.41M$ 507.26M$ 461.11M
Depreciation and Amortization
$ 28.90M$ 23.36M$ 20.45M$ 18.39M$ 13.92M
EBITDA
$ -232.30M$ -113.16M$ -477.87M$ -416.54M$ -392.38M
Operating Income
$ -136.50M$ -303.24M$ -439.49M$ -455.62M$ -392.29M
Other Income/Expenses
$ -146.10M$ 145.11M$ -80.63M$ 9.90M$ -14.91M
Pretax Income
$ -282.60M$ -158.13M$ -520.12M$ -445.72M$ -407.20M
Net Income
$ -296.80M$ -177.03M$ -518.25M$ -446.35M$ -403.58M
Per Share Metrics
Basic EPS
$ -1.60$ -0.97$ -2.94$ -2.81$ -2.74
Diluted EPS
$ -1.60$ -0.97$ -2.94$ -2.81$ -2.74
Weighted Average Shares Outstanding
 184.32M 182.85M 176.08M 159.04M 140.85M
Weighted Average Shares Outstanding (Diluted)
 184.32M 182.85M 176.08M 159.04M 140.85M
Currency in USD

Legend Biotech Earnings and Revenue History